Show simple item record

dc.contributor.authorJayne, Daviden
dc.date.accessioned2020-02-22T00:31:29Z
dc.date.available2020-02-22T00:31:29Z
dc.date.issued2019-11en
dc.identifier.issn1769-7255
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/302584
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectHumansen
dc.subjectAniline Compoundsen
dc.subjectNipecotic Acidsen
dc.subjectAntibodies, Monoclonalen
dc.subjectComplement Pathway, Alternativeen
dc.subjectNeutrophil Activationen
dc.subjectComplement C5aen
dc.subjectComplement Inactivating Agentsen
dc.subjectClinical Trials, Phase II as Topicen
dc.subjectAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitisen
dc.titleComplement inhibition in ANCA vasculitis.en
dc.typeArticle
prism.endingPage412
prism.issueIdentifier6en
prism.publicationDate2019en
prism.publicationNameNephrologie & therapeutiqueen
prism.startingPage409
prism.volume15en
dc.identifier.doi10.17863/CAM.49652
dcterms.dateAccepted2019-04-12en
rioxxterms.versionofrecord10.1016/j.nephro.2019.04.001en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-11en
dc.contributor.orcidJayne, David [0000-0002-1712-0637]
dc.identifier.eissn1872-9177
rioxxterms.typeJournal Article/Reviewen
cam.orpheus.successTue Mar 31 10:35:39 BST 2020 - Embargo updated*
rioxxterms.freetoread.startdate2020-11-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International